Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

Sanofi has previously taken other measures to make it easier for diabetes patients and payers to access insulin products, including the launch of an unbranded insulin glargine last year at a 60% ...

Attorneys for the school district say that the legal action is in part due to self-funded insurance plans that has possibly ...

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Sanofi has formed another partnership to support its vision of insulin-based therapies that are connected with glucose monitoring devices and make it easier for patients to manage their blood ...

Pharmaceutical giant Sanofi has capped the price of its insulin, becoming the last of three major manufacturers of the drug to curb soaring costs of the lifesaving medication in the US.

The three largest insulin makers – Novo Nordisk, Sanofi and Eli Lilly - implemented price cuts of up to 78% for some of their ...

has guaranteed that Wyoming residents not enrolled in government healthcare programs can buy insulin products for $35 each month for the next five years. The settlement announced by Attorney ...

Its main competitors in the insulin market, Novo Nordisk and Eli Lilly, in recent years launched blockbuster weight-loss drugs that have sent their market values soaring. Hudson said Sanofi does ...

GoodRx said in a statement that it is working with Sanofi to offer U.S. insulin ... Other companies that have begun offering $35 insulin products this year include Hy-Vee, which launched a program ...

and packaging of Sanofi’s SoloStar insulin pens and advanced insulin products. This strategic partnership reinforces our commitment to reduce the burden of importing medicines, increase access to high ...